The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Erythropoietin protects against ischaemic acute renal injury
Abstract
BACKGROUND: Erythropoietin (EPO) has recently been shown to exert important cytoprotective and anti-apoptotic effects in experimental brain injury and cisplatin-induced nephrotoxicity. The aim of the present study was to determine whether EPO administration is also renoprotective in both in vitro and in vivo models of ischaemic acute renal failure. METHODS: Primary cultures of human proximal tubule cells (PTCs) were exposed to either vehicle or EPO (6.25-400 IU/ml) in the presence of hypoxia (1% O(2)), normoxia (21% O(2)) or hypoxia followed by normoxia for up to 24 h. The end-points evaluated included cell apoptosis (morphology and in situ end labelling [ISEL], viability [lactate dehydrogenase (LDH release)], cell proliferation [proliferating cell nuclear antigen (PCNA)] and DNA synthesis (thymidine incorporation). The effects of EPO pre-treatment (5000 U/kg) on renal morphology and function were also studied in rat models of unilateral and bilateral ischaemia-reperfusion (IR) injury. RESULTS: In the in vitro model, hypoxia (1% O(2)) induced a significant degree of PTC apoptosis, which was substantially reduced by co-incubation with EPO at 24 h (vehicle 2.5+/-0.5% vs 25 IU/ml EPO 1.8+/-0.4% vs 200 IU/ml EPO 0.9+/-0.2%, n = 9, P<0.05). At high concentrations (400 IU/ml), EPO also stimulated thymidine incorporation in cells exposed to hypoxia with or without subsequent normoxia. LDH release was not significantly affected. In the unilateral IR model, EPO pre-treatment significantly attenuated outer medullary thick ascending limb (TAL) apoptosis (EPO 2.2+/-1.0% of cells vs vehicle 6.5+/-2.2%, P<0.05, n = 5) and potentiated mitosis (EPO 1.1+/-0.3% vs vehicle 0.5+/-0.3%, respectively, P<0.05) within 24 h. EPO-treated rats exhibited enhanced PCNA staining within the proximal straight tubule (6.9+/-0.7% vs vehicle 2.4+/-0.5% vs sham 0.3+/-0.2%, P<0.05), proximal convoluted tubule (2.3+/-0.6% vs vehicle 1.1+/-0.3% vs sham 1.2+/-0.3%, P<0.05) and TAL (4.7+/-0.9% vs vehicle 0.6+/-0.3% vs sham 0.3+/-0.2%, P<0.05). The frequency of tubular profiles with luminal cast material was also reduced (32.0+/-1.6 vs vehicle 37.0+/-1.3%, P = 0.05). EPO-treated rats subjected to bilateral IR injury exhibited similar histological improvements to the unilateral IR injury model, as well as significantly lower peak plasma creatinine concentrations than their vehicle-treated controls (0.04+/-0.01 vs 0.21+/-0.08 mmol/l, respectively, P<0.05). EPO had no effect on renal function in sham-operated controls. CONCLUSIONS: The results suggest that, in addition to its well-known erythropoietic effects, EPO inhibits apoptotic cell death, enhances tubular epithelial regeneration and promotes renal functional recovery in hypoxic or ischaemic acute renal injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Epidemiology of acute renal failure: A prospective, multicenter, community-based study
Liaño, F., Pascual, J., & The Madrid Acute Renal Failure Study Group (1996) · Kidney International · doi:10.1038/ki.1996.380 · Cited by 978
In vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949
Digicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
INCREASED MORTALITY ASSOCIATED WITH GROWTH HORMONE TREATMENT IN CRITICALLY ILL ADULTS
Akala, J. U. T., Uokonen, E. S. R., Igel, N., Ebster, R. W., Ielsen, M. I. S. N., Andstra, D. U. F. Z., Undelinckx, G. U. V., & Inds, H. J. H. (1999) · Cited by 889
A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715
Ansari, B., Coates, P. J., Greenstein, B. D., & Hall, P. A. (1993) · The Journal of Pathology · doi:10.1002/path.1711700102 · Cited by 577
Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.
Anagnostou, A., Lee, E. S., Kessimian, N., Levinson, R., & Steiner, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5978 · Cited by 569
Walker, N. I., HARMON, B. V., Gobe, G. C., & Kerr, J. F. R. (1988) · PubMed · Cited by 527
Gregory, T., Yu, C., Ma, A., Orkin, S. H., Blobel, G. A., & Weiss, M. J. (1999) · Blood · doi:10.1182/blood.v94.1.87.413k41_87_96 · Cited by 366
Hirschberg, R., Kopple, J., Lipsett, P., Benjamin, E., Minei, J., Albertson, T., Munger, M., Metzler, M., Zaloga, G., Murray, M., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00463.x · Cited by 305
Silva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nuñez, G., & Fernandez-Luna, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22165 · Cited by 277
Erythropoietin Stimulates Proliferation and Interferes with Differentiation of Myoblasts
Ogilvie, M., Yu, X., Nicolas-Metral, V., Pulido, S. M., Liu, C., Ruegg, U. T., & Noguchi, C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004999200 · Cited by 262
Human, rat, and mouse kidney cells express functional erythropoietin receptors
Westenfelder, C., Biddle, D. L., & Baranowski, R. L. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003808.x · Cited by 246
Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation
Calapai, G., Marciano, M. C., Corica, F., Allegra, A., Parisi, A., Frisina, N., Caputi, A. P., & Buemi, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00466-0 · Cited by 235
Acute renal failure. Madrid Acute Renal Failure Study Group.
Liaño, G., & Pascual, J. (1996) · PubMed · Cited by 194
GOBÉ, G., ZHANG, X.-J., WILLGOSS, D. A., SCHOCH, E., HOGG, N. A., & ENDRE, Z. H. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113454 · Cited by 182
Paracrine stimulation of human renal fibroblasts by proximal tubule cells
Johnson, D. W., Saunders, H. J., Baxter, R. C., Field, M. J., & Pollock, C. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00048.x · Cited by 140
Erythropoietin enhances recovery after cisplatin‐induced acute renal failure in the rat
Bagnis, C. I., Beaufils, H., Jacquiaud, C., Adabra, Y., Jouanneau, C., Nahour, G. L., Jaudon, M. C., Bourbouze, R., Jacobs, C., & Deray, G. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.5.932 · Cited by 129
Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity
Sinor, A. D., & Greenberg, D. A. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01361-6 · Cited by 119
Yasuda, Y., Musha, T., Tanaka, H., Fujita, Y., Fujita, H., Utsumi, H., Matsuo, T., Masuda, S., Nagao, M., Sasaki, R., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1666 · Cited by 101
Increased mortality associated with growth hormone treatment in critically ill adults.
den Berghe, G. V. (2000) · PubMed · Cited by 98
Ammarguellat, F., Gogusev, J., & Drüeke, T. B. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027361 · Cited by 89
Erythropoietin enhances recovery from cisplatin-induced acute renal failure
Vaziri, N. D., Zhou, X., & Liao, S. Y. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.3.f360 · Cited by 76
Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia
Wilcox, C. S., Deng, X., Doll, A. H., Snellen, H. G., & Welch, W. J. (1993) · Kidney International · doi:10.1038/ki.1993.261 · Cited by 67
Beyond erythropoiesis: Novel applications for recombinant human erythropoietin
Cerami, A. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90128-3 · Cited by 66
Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis
Johnson, D. W., Saunders, H. J., Brew, B. K., Ganesan, A. N., Baxter, R. C., Poronnik, P., Cook, D. I., Gyory, A. Z., Field, M. J., & Pollock, C. A. (1997) · Kidney International · doi:10.1038/ki.1997.479 · Cited by 54
Kusano, E., Akimoto, T., Inoue, M., Masunaga, Y., Umino, T., Ono, S., Ando, Y., Homma, S., Muto, S., Komatsu, N., et al. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.3.597 · Cited by 31
Transport characteristics of human proximal tubule cells in primary culture
Johnson, D. W., Brew, B. K., Poronnik, P., Cook, D. I., Gyory, A. Z., Field, M. J., & Pollock, C. A. (1997) · Nephrology · doi:10.1111/j.1440-1797.1997.tb00213.x · Cited by 30
Cited by
Update on Mechanisms of Ischemic Acute Kidney Injury
Devarajan, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010017 · Cited by 1,026
“Similarly, erythropoietin, used extensively in humans for stimulating erythropoiesis, also has prominent antiapoptotic and antiinflammatory actions (179) and has been used successfully for functional amelioration of ischemic AKI in animals (65,77,180).”
BackgroundCardiorenal Syndrome: New Perspectives
Bock, J. S., & Gottlieb, S. S. (2010) · Circulation · doi:10.1161/circulationaha.109.886473 · Cited by 455
The non‐haematopoietic biological effects of erythropoietin
Arcasoy, M. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07014.x · Cited by 347
Brines, M., & Cerami, A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02024.x · Cited by 333
Hypoxia-inducible factors in the kidney
Haase, V. H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00071.2006 · Cited by 332
Metadata
- Authors
- Vesey, D. A.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-01
- Volume
- 19
- Issue
- 2
- Pages
- 348-355
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2137002490
- Cited by
- 286
- References
- 31
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.